Mark Shearman

Vorstandsvorsitzender bei

Aprinoia Therapeutics, Inc. /US/

64 Jahre

Health Technology

Consumer Services

Profil

Mark S.
Shearman is currently the Chief Executive Officer & Director at Aprinoia Therapeutics, Inc. He previously held positions as the Executive Director-Neuroscience at Merck & Co., Inc., the Executive Director at Merck Research Laboratories Massachusetts LLC, and the Senior Director-Cellular & Molecular Neuroscience at Merck Sharp & Dohme Research Laboratories Neuroscience Research.
He also served as the Senior VP-Research & Early Development at Merck KGaA and the Chief Scientific Officer & Vice President at Beacon Therapeutics (USA), Inc. Dr. Shearman's most recent former position was as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. He received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.

Aktive Positionen von Mark Shearman

Unternehmen	Position	Beginn
Aprinoia Therapeutics, Inc. /US/ Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases	Vorstandsvorsitzender	14.07.2023

Alle aktiven Positionen von Mark Shearman

Ehemalige bekannte Positionen von Mark Shearman

Unternehmen	Position	Ende
APPLIED GENETIC TECHNOLOGIES CORPORATION	Technik-/Wissenschafts-/F&E-Leiter	20.04.2021
MERCK KGAA	Corporate Officer/Principal	01.01.2015
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Direktor/Vorstandsmitglied	01.07.2009
MERCK & CO., INC.	Corporate Officer/Principal	01.01.2009
Merck Sharp & Dohme Research Laboratories Neuroscience Researc	Corporate Officer/Principal	01.01.2005

Sehen Sie sich die Erfahrung von Mark Shearman im Detail an

Ausbildung von Mark Shearman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mark Shearman im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	10
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services	Health Technology
The University of Nottingham The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Health Technology
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
Editas Medicine, Inc. Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines	Health Technology
Merck Sharp & Dohme Research Laboratories Neuroscience Researc
Aprinoia Therapeutics, Inc. /US/ Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases	Health Technology